45 related articles for article (PubMed ID: 37470572)
21. Hypoglossal nerve delineation in nasopharyngeal carcinoma patients may reduce the radiation dose and damage to the nerve.
Chen F; Jen YM; He K; Yin ZS; Lee JC; Huang WY; Tang YH
Med Dosim; 2024 Summer; 49(2):102-108. PubMed ID: 37858458
[TBL] [Abstract][Full Text] [Related]
22. Specific-CT brain template construction and retrospective dosimetric comparison study in brain for nasopharyngeal carcinoma patients treated with IMRT or VMAT.
Du F; Zheng S; Shao K; Yang Y; Chen W; Bai X; Hua Y
Am J Cancer Res; 2024; 14(4):1662-1674. PubMed ID: 38726278
[TBL] [Abstract][Full Text] [Related]
23. Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study.
Wu AK; Damico NJ; Healy E; Kharouta MZ; Khandel G; Deshane A; Sipos J; Eckstein J; Zoller W; Ewing A; Ling S; Wobb J; Mitchell D; Grecula J; Jhawar S; Miller E; Gamez M; Diavolitsis V; Blakaj D; Bhatt AD
Tech Innov Patient Support Radiat Oncol; 2021 Dec; 20():28-34. PubMed ID: 34765751
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of intensity-modulated radiotherapy to treat gastric cancer.
Skrobala A; Adamczyk M; Karczewska-Dzionk A
Rep Pract Oncol Radiother; 2019; 24(1):68-73. PubMed ID: 30479581
[TBL] [Abstract][Full Text] [Related]
25. Dosimetric Effects of Head and Neck Immobilization Devices on Multi-field Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Chen L; Peng YL; Gu SY; Shen H; Zhang DD; Sun WZ; Wu JH; Deng XW
J Cancer; 2018; 9(14):2443-2450. PubMed ID: 30026841
[No Abstract] [Full Text] [Related]
26. Development and Validation of Single-Optimization Knowledge-Based Volumetric Modulated Arc Therapy Model Plan in Nasopharyngeal Carcinomas.
Sinha S; Kumar A; Maheshwari G; Mohanty S; Joshi K; Shinde P; Gupta D; Kale S; Phurailatpam R; Swain M; Budrukkar A; Kinhikar R; Ghosh-Laskar S
Adv Radiat Oncol; 2024 Jan; 9(1):101311. PubMed ID: 38260222
[TBL] [Abstract][Full Text] [Related]
27. Intensity modulated radiotherapy: advantages, limitations and future developments.
Cheung K
Biomed Imaging Interv J; 2006 Jan; 2(1):e19. PubMed ID: 21614217
[TBL] [Abstract][Full Text] [Related]
28. Effect of relevant factors on radiation-induced nasopharyngeal ulcer in patients with primary nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.
Fei Z; Chen T; Qiu X; Chen C
Laryngoscope Investig Otolaryngol; 2020 Apr; 5(2):228-234. PubMed ID: 32337354
[TBL] [Abstract][Full Text] [Related]
29. When is better best? A multiobjective perspective.
Phillips MH; Holdsworth C
Med Phys; 2011 Mar; 38(3):1635-40. PubMed ID: 21520876
[TBL] [Abstract][Full Text] [Related]
30. Risk factors associated with ototoxicity in long-term nasopharyngeal carcinoma survivors.
He S; Yu H; He L; Liu M; He Y; Peng X; Ai P
Oral Oncol; 2024 Jul; 154():106827. PubMed ID: 38735130
[TBL] [Abstract][Full Text] [Related]
31. Correction: Evolution of radiation-induced temporal lobe injury after intensity-modulated radiation therapy in nasopharyngeal carcinoma: a large cohort retrospective study.
Hou J; He Y; Li H; Ai Z; Lu Q; Zeng B; Xie C; Yu X
Radiat Oncol; 2024 Mar; 19(1):41. PubMed ID: 38539196
[No Abstract] [Full Text] [Related]
32. Delineating and sparing the ileal conduit in adjuvant radiotherapy for bladder cancer with modulated radiotherapy.
Goyal S; Vias P; Periasamy K; Madan R; Trivedi G; Devana SK; Prashar H; Khosla D
J Cancer Res Ther; 2023; 19(3):731-737. PubMed ID: 37470602
[TBL] [Abstract][Full Text] [Related]
33. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
34. Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT.
Lu SH; Cheng JC; Kuo SH; Lee JJ; Chen LH; Wu JK; Chen YH; Chen WY; Wen SY; Chong FC; Wu CJ; Wang CW
Radiother Oncol; 2012 Sep; 104(3):324-30. PubMed ID: 22236614
[TBL] [Abstract][Full Text] [Related]
35. A dosimetric comparison of intensity-modulated radiotherapy versus rapid arc in gynecological malignancies: Dose beyond planning target volume, precisely 5Gy volume.
Sidhu MS; Singh K; Sood S; Aggarwal R
J Cancer Res Ther; 2023; 19(5):1267-1271. PubMed ID: 37787294
[TBL] [Abstract][Full Text] [Related]
36. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
[TBL] [Abstract][Full Text] [Related]
37. A plan comparison study between rapid arc and conventional intensity-modulated radiation treatment plans in nasopharyngeal carcinoma patients.
Patidar Y; Kumar HS; Sharma N; Mayilvaganan A
J Cancer Res Ther; 2023; 19(3):543-547. PubMed ID: 37470572
[TBL] [Abstract][Full Text] [Related]
38.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]